Detalhe da pesquisa
1.
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.
Gut
; 71(2): 287-295, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34344783
2.
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
Clin Gastroenterol Hepatol
; 20(6): e1263-e1282, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954338
3.
Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.
J Crohns Colitis
; 18(1): 38-46, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465992
4.
Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
Inflamm Bowel Dis
; 30(1): 1-8, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917191
5.
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.
Inflamm Bowel Dis
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578929
6.
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
Inflamm Bowel Dis
; 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190498
7.
Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
J Crohns Colitis
; 17(10): 1614-1623, 2023 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099729
8.
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN.
J Crohns Colitis
; 17(9): 1410-1417, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084088
9.
Pre- and Perinatal Factors Predicting Inflammatory Bowel Disease: A Population-Based Study with Fifty Years of Follow-Up.
J Crohns Colitis
; 16(9): 1397-1404, 2022 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35299254